Drug Trial Radar · NCT04029116
Phase 3 Study of Oral Ibrexafungerp (SCY-078) Vs. Placebo in Subjects With Recurrent Vulvovaginal Candidiasis (VVC)
Last checked: Nov 20, 2026Latest source record: Jun 18, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
440
Actual
Start
Oct 21, 2019
Primary completion
Sep 1, 2021
Study completion Nov 29, 2021
Sponsor
- Lead sponsor
- Scynexis, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jul 23, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of oral ibrexafungerp (formerly "SCY-078") compared to placebo in female subjects 12 years and older with recurrent VVC (RVVC).
Conditions
- Recurrent Vulvovaginal Candidiasis
Interventions
Fluconazole TabletDrug
150 mg every 72 hours for 3 doses
IBREXAFUNGERPDrug
300 mg BID (one day) every 4 weeks for a total of 6 dosing days
Placebo oral tabletDrug
BID (one day) every 4 weeks for a total of 6 dosing days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Clinical SuccessTime frame: Week 24
Locations
25 sites in 1 country. Site status is shown where the registry gives one.
Precision Trials LLC
Phoenix, Arizona
Women's Healthcare Research Corp
San Diego, California
Altus Research - Hunt - PPDS
Lake Worth, Florida
New Age Medical Research Corporation
Miami, Florida
Healthcare Clinical Data Inc
North Miami, Florida
Clinical Research Prime - ClinEdge - PPDS
Idaho Falls, Idaho
Clinical Trials Management
Covington, Louisiana
Women Under Study, LLC
New Orleans, Louisiana
Unified Women's Clinical Research
Hagerstown, Maryland
Wayne State University
Detroit, Michigan
Center For Women's Health and Wellness LLC
Lawrenceville, New Jersey
Lawrence Obstetrics Gynecology Clinical Research LLC
Lawrenceville, New Jersey
Bosque Women's Care
Albuquerque, New Mexico
Carolina Women's Research and Wellness Center
Durham, North Carolina
Unified Womens CLinical Research
Greensboro, North Carolina
Unified Women's Clinical Research Raleigh
Raleigh, North Carolina
M3 Wake Research, Inc
Raleigh, North Carolina
Group For Women
Winston-Salem, North Carolina
Lyndhurst Clinical Research
Winston-Salem, North Carolina
Cleveland Clinic
Cleveland, Ohio
Obstetrics and Gynecology Associates of Erie, PC
Erie, Pennsylvania
Jefferson University Hospital
Philadelphia, Pennsylvania
Chattanooga Medical Research Inc
Chattanooga, Tennessee
Medical Research Center of Memphis, LLC
Memphis, Tennessee
TMC Life Research Inc
Houston, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.